Roles of astrocytes in synaptic transmission and plasticity
The research area of this proposal is Life Science at the intersection of neuroscience, pharmacology and physiology. In the central nervous system (CNS), astrocytes are both numerous and complex. They contact most other cell types...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
BFU2017-83292-R
POTENCIACION DE LA TRANSMISION SINAPTICA POR EL RECEPTOR MGL...
218K€
Cerrado
BFU2010-18297
FUNCION DE NEUROGRANINA EN LA PLASTICIDAD SINAPTICA
24K€
Cerrado
PLASTINHIB
Molecular Plasticity of Inhibitory Synapses
2M€
Cerrado
AstroWireSyn
Wiring synaptic circuits with astroglial connexins mechanis...
2M€
Cerrado
SAF2008-04616
REGULACION DE LA PLASTICIDAD SINAPTICA FOR FOSFOINOSITIDOS
188K€
Cerrado
ADOS
AMPA Receptor Dynamic Organization and Synaptic transmission...
2M€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The research area of this proposal is Life Science at the intersection of neuroscience, pharmacology and physiology. In the central nervous system (CNS), astrocytes are both numerous and complex. They contact most other cell types in the CNS, and the processes of a single astrocyte can envelop as many as 140,000 synapses. Thus, these cells are uniquely able to receive signals from many sources, in particular synapses, via their G protein-coupled receptors (GPCRs). Additionally, using conventional pharmacological approaches, it has suggested that astrocytes can also send signals to neurons by release of various transmitters to modulate synaptic transmission and plasticity. This reciprocal signaling between neurons and astrocytes (gliotransmission) is still a novel concept, and its physiological relevance remains controversial in the field. In the first part of this proposal, we propose to use novel pharmacogenetic tools that will allow us to selectively activate astrocytes vs. neurons in a more physiological manner to further test the concept of gliotransmission and its role in sleep and memory in vivo. In the second part of this proposal, we will take advantage of these powerful pharmacogenetic tools to test a hypothesis that has heretofore been inaccessible to experimentation, i.e., the possibility that astrocyte GPCRs control glycogen metabolism to modulate synaptic transmission, plasticity, sleep and memory formation. Addressing successfully such major questions in the field of neuroscience, and in particular, resolving some controversies about gliotransmission has profound implications in our understanding of the brain, but also and importantly ,in the clinic. From these studies, we are likely to resolve important aspects of astrocyte function and open up entirely new areas of investigation; this work may lead to potential treatments of diseases, including Alzheimer disease and memory and sleep disorders.